https://rheumatology.medicinematters.com/axial-spondyloarthritis/ixekizumab-/coast-y-ixekizumab-retreatment-after-withdrawal/23529990
0
0
38 words
0
Comments
Most patients with axial spondyloarthritis who stop taking ixekizumab respond to the treatment when it is reintroduced following disease flare, analysis of COAST-Y data suggests.
You are the first to view
Create an account or login to join the discussion